These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8889849

  • 1. Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group.
    Van Beek E, Löwik C, Que I, Papapoulos S.
    J Bone Miner Res; 1996 Oct; 11(10):1492-7. PubMed ID: 8889849
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum.
    Brown RJ, van Beek E, Watts DJ, Löwik CW, Papapoulos SE.
    J Bone Miner Res; 1998 Feb; 13(2):253-8. PubMed ID: 9495518
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonates: structure-activity relations from a clinical perspective.
    Papapoulos SE.
    Medicina (B Aires); 1997 Feb; 57 Suppl 1():61-4. PubMed ID: 9567357
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Structural requirements for bisphosphonate actions in vitro.
    van Beek E, Hoekstra M, van de Ruit M, Löwik C, Papapoulos S.
    J Bone Miner Res; 1994 Dec; 9(12):1875-82. PubMed ID: 7872052
    [Abstract] [Full Text] [Related]

  • 6. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.
    Mönkkönen J, Taskinen M, Auriola SO, Urtti A.
    J Drug Target; 1994 Dec; 2(4):299-308. PubMed ID: 7858955
    [Abstract] [Full Text] [Related]

  • 7. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
    Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC.
    Cancer Res; 2000 Nov 01; 60(21):6001-7. PubMed ID: 11085520
    [Abstract] [Full Text] [Related]

  • 8. Antiresorptive dose-response relationships across three generations of bisphosphonates.
    Sietsema WK, Ebetino FH, Salvagno AM, Bevan JA.
    Drugs Exp Clin Res; 1989 Nov 01; 15(9):389-96. PubMed ID: 2630251
    [Abstract] [Full Text] [Related]

  • 9. Modulation of cytosolic calcium levels in osteoblast-like osteosarcoma cells by olpadronate and its amino-derivative IG-9402.
    Vazquez G, Santillan G, Boland R, Roldán E, Pérez-Lloret A.
    Calcif Tissue Int; 2003 Mar 01; 72(3):215-21. PubMed ID: 12469251
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
    Yang M, Burton DW, Geller J, Hillegonds DJ, Hastings RH, Deftos LJ, Hoffman RM.
    Clin Cancer Res; 2006 Apr 15; 12(8):2602-6. PubMed ID: 16638872
    [Abstract] [Full Text] [Related]

  • 15. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates.
    van beek E, Löwik C, van der Pluijm G, Papapoulos S.
    J Bone Miner Res; 1999 May 15; 14(5):722-9. PubMed ID: 10320520
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
    Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH.
    Bone; 2006 May 15; 38(5):617-27. PubMed ID: 16046206
    [Abstract] [Full Text] [Related]

  • 19. Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats.
    Azuma Y, Oue Y, Kanatani H, Ohta T, Kiyoki M, Komoriya K.
    J Pharmacol Exp Ther; 1998 Jul 15; 286(1):128-35. PubMed ID: 9655851
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the trabecular rat bone mineral: effect of ovariectomy and bisphosphonate treatment.
    Bohic S, Rey C, Legrand A, Sfihi H, Rohanizadeh R, Martel C, Barbier A, Daculsi G.
    Bone; 2000 Apr 15; 26(4):341-8. PubMed ID: 10719276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.